Absci shares are rising after announcing a strategic collaboration with Advanced Micro Devices Inc. The partnership will enhance Absci’s AI drug discovery capabilities using AMD Instinct accelerators and ROCm software. read more
Helen of Troy reported a 3.4% year-on-year decline in Q3 FY25 sales,. The decline in sales was mainly attributed to weaker performance in the Beauty & Wellness segment, which saw a 9.3% drop. read more
Bitcoin (CRYPTO: BTC) continues to slide following Tuesday’s stronger-than-expected December Purchasing Managers’ Index reading, read more
For technical roles, candidates must demonstrate exceptional ability and provide a contact number. read more
Acuity Brands reports 1.8% YoY net sales growth of $951.6 million in Q1 2025, beating EPS estimates and expanding margins. Stock up 49% in a year. read more
Latest Ratings for FHI Date Firm Action From To Feb 2022 Deutsche Bank Maintains Buy Apr 2021 JP Morgan Downgrades Neutral Underweight Oct 2020 JP Morgan Downgrades Overweight Neutral View More Analyst Ratings for FHI View the Latest Analyst Ratings read more
Latest Ratings for REGN Date Firm Action From To Feb 2022 Truist Securities Maintains Buy Feb 2022 Oppenheimer Maintains Outperform Feb 2022 Morgan Stanley Maintains Equal-Weight View More Analyst Ratings for REGN View the Latest Analyst Ratings read more
Latest Ratings for SN Date Firm Action From To Aug 2018 RBC Capital Downgrades Outperform Sector Perform Apr 2018 KLR Group Downgrades Buy Hold Feb 2018 Northland Capital Markets Downgrades Outperform Market Perform View More Analyst Ratings for SN View the Latest Analyst Ratings read more
Latest Ratings for GL Date Firm Action From To Feb 2022 Morgan Stanley Maintains Underweight Jan 2022 Jefferies Initiates Coverage On Hold Jan 2022 Wolfe Research Initiates Coverage On Underperform View More Analyst Ratings for GL View the Latest Analyst Ratings read more